T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
CNA Financial
CNA
$13.7B
| $231M | 0.03% |
5,050,132
+203,165
| +4% | +$9.39M |
|
452
Liberty Global Class C
LBTYK
$3.46B
| $230M | 0.03% |
8,174,649
-6,265,286
| -43% | -$169M |
|
453
Sunstone Hotel Investors
SHO
$2.01B
| $229M | 0.03% |
14,011,993
+1,006,027
| +8% | +$16.6M |
|
454
Texas Capital Bancshares
TCBI
$4.38B
| $227M | 0.03% |
2,751,023
-59,010
| -2% | -$5.35M |
|
455
Boston Properties
BXP
$10.8B
| $227M | 0.03% |
1,840,667
-71,094
| -4% | -$9.05M |
|
|
BPMC
456
DELISTED
Blueprint Medicines
BPMC
| $225M | 0.03% |
2,884,347
-237,971
| -8% | -$16.5M |
|
457
Watsco Inc
WSO
$12.8B
| $224M | 0.03% |
1,259,902
-362,466
| -22% | -$64M |
|
458
Southwest Gas
SWX
$6.68B
| $223M | 0.03% |
2,826,504
+416,183
| +17% | +$32.9M |
|
459
Euronet Worldwide
EEFT
$2.66B
| $223M | 0.03% |
2,228,666
+1,427,185
| +178% | +$134M |
|
460
Acadia Realty Trust
AKR
$2.84B
| $223M | 0.03% |
7,967,507
+438,927
| +6% | +$12.1M |
|
461
Urban Edge Properties
UE
$2.75B
| $223M | 0.03% |
10,106,757
-335,965
| -3% | -$7.57M |
|
|
ONC
462
BeOne Medicines Ltd
ONC
$40.6B
| $221M | 0.03% |
1,284,783
-132,295
| -9% | -$22.2M |
|
463
Fortune Brands Innovations
FBIN
$5.83B
| $220M | 0.03% |
4,921,329
+1,901,504
| +63% | +$89.4M |
|
464
Agios Pharmaceuticals
AGIO
$2.04B
| $218M | 0.03% |
2,830,017
-116,792
| -4% | -$9.4M |
|
465
Alexandria Real Estate Equities
ARE
$8.27B
| $218M | 0.03% |
1,732,451
-7,507
| -0.4% | -$949K |
|
466
Novanta
NOVT
$6.32B
| $218M | 0.03% |
3,180,465
-509,096
| -14% | -$35.7M |
|
467
Pentair
PNR
$10.5B
| $216M | 0.03% |
4,980,871
-20,296
| -0.4% | -$880K |
|
|
SPR
468
DELISTED
Spirit AeroSystems
SPR
| $215M | 0.03% |
2,343,708
+230,242
| +11% | +$20.2M |
|
|
PX
469
DELISTED
Praxair Inc
PX
| $215M | 0.03% |
1,335,955
-17,627
| -1% | -$2.83M |
|
|
B
470
Barrick Mining
B
$67.9B
| $213M | 0.03% |
19,193,905
+8,957,554
| +88% | +$99.7M |
|
471
Motorola Solutions
MSI
$77.7B
| $212M | 0.03% |
1,631,979
+763,688
| +88% | +$94.5M |
|
472
Insmed
INSM
$28.9B
| $212M | 0.03% |
10,500,244
-1,999,246
| -16% | -$45.1M |
|
473
Ultragenyx Pharmaceutical
RARE
$2.65B
| $212M | 0.03% |
2,778,029
-18,363
| -0.7% | -$1.49M |
|
474
Kilroy Realty
KRC
$4.22B
| $210M | 0.03% |
2,935,628
-304,553
| -9% | -$22.2M |
|
475
Zillow
Z
$7.48B
| $209M | 0.03% |
4,733,753
+1,435,726
| +44% | +$74.9M |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.